ICON’s Flex Advantage IRT Platform
Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Flex Advantage features:
- Randomization engine that can be adjusted mid-study or dynamically
- Plug-and-play modules for easier configuration
- Emergency unblinding support
- Enhanced reporting with customizable dashboard
- Integration with ICON products, such as ADDPLAN, Firecrest and ICONIK as well as external EDC, drug distributor and drug supply forecasting systems
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
